Virtus LifeSci Biotech Clinical Trials ETF: (BBC)
(Delayed Data from NYSE) As of Aug 23, 2024 03:55 PM ET
$27.78 USD
+0.61 (2.25%)
Volume: 1,089
ETF Quote Details
Previous Close | 27.17 |
Open | 27.91 |
Bid | 26.78 |
Ask | 28.42 |
Day Low-High | 27.91-27.94 |
52wk Low-High | 16.88-31.99 |
Volume | 1,089 |
NAV (month end) | 28.86 |
Premium (+)/Discount (-) (month end) | -1.69 |
ETF Expense Ratio
Expense Ratio | 0.79% |
Dividend (Yield) | $0.08 (0.30%) |
Issuer | VIRTUS INVESTMENT PARTNERS INC |
Benchmark for BBC
LIFESCI BIOTECH CLINICAL TRIALS INDEX
The LifeSci Biotechnology Clinical Trials Index is an equal weighted index that is designed to measure the equity market performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering that is in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development.
Fund Summary for BBC
VIRTUS LIFESCI BIOTECH CLINCL TRIALS ETF
The Virtus LifeSci Biotech Clinical Trials ETF seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index.